JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB100617

Human Osteoprotegerin ELISA Kit

Be the first to review this product! Submit a review

|

(21 Publications)

Human Osteoprotegerin ELISA Kit is a sandwich ELISA designed to quantify Human Osteoprotegerin with a sensitivity of 1 pg/mL.

- Colorimetric sandwich ELISA - 450 nm readout - works on any plate reader
- Wide dynamic range - quantifies 1.23 - 900 pg/mL
- Cited in over 10 publications

View Alternative Names

OCIF, OPG, TNFRSF11B, Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin

4 Images
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
  • sELISA

Supplier Data

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)

Representative Standard Curve using ab100617.

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
  • sELISA

Supplier Data

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)

Representative Standard Curve using ab100617.

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
  • sELISA

Lab

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)
  • sELISA

Lab

Sandwich ELISA - Human Osteoprotegerin ELISA Kit (AB100617)

Osteoprotegerin measured in cell lysates showing quantity (pg) per mg of tested sample

Key facts

Detection method

Colorimetric

Sample types

Plasma, Cell culture supernatant, Serum, Cell Lysate

Reacts with

Human

Assay type

Sandwich

Results type

Quantitative

Sensitivity

< 1 pg/mL

Range

1.23 - 900 pg/mL

Assay Platform

Microplate

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Human Osteoprotegerin ELISA Kit ab100617 is a sandwich ELISA to measure Human Osteoprotegerin in serum, plasma, cell culture supernatant, cell lysate with a sensitivity of 1 pg/ml.

How the assay works

This assay employs an antibody specific for Human Osteoprotegerin coated on a 96-well plate. Standards and samples are pipetted into the wells and Osteoprotegerin present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-Human Osteoprotegerin antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of Osteoprotegerin bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.
Produced using a non-baculovirus expression system.

Assay Specificity

Our ELISA kits are rigorously validated to ensure the highest level of consistency and reproducibility. Please check the protocol booklet for more details

Human Osteoprotegerin ELISA Kit ab100617 protocol summary

1. Add standard or sample to each well used. Incubate at room temperature
2. Wash and add prepared biotinylated antibody to each well. Incubate at room temperature.
3. Wash and add prepared streptavidin solution. Incubate at room temperature.
4. Add TMB Development Solution to each well. Incubate at room temperature.
5. Add Stop Solution to each well. Read at 450nm immediately.

Get results in 90 minutes with our SimpleStep ELISA® kit

Human Osteoprotegerin ELISA Kit (ab189580)

Optimization may be required with urine samples.

We recommend preparing serum-free or low-serum medium samples, as serum tends to contain cytokines which may produce significant background signals. If it is necessary to test serum-containing medium, we recommend also running an uncultured media blank to assess baseline signals. This baseline can then be subtracted from the cultured media sample data.

Recovery

[ { "sample": "Cell culture supernatant", "range": "89 - 108 %", "average": "= 99.75" }, { "sample": "Serum", "range": "89 - 108 %", "average": "= 99.85" }, { "sample": "Plasma", "range": "90 - 109 %", "average": "= 102.45" } ]

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab100617-1x96Tests", "assetComponentDetails": [ { "size":"1 x 25 mL", "name":"20X Wash Buffer", "number":"AB100617-CMP04", "productcode":"" }, { "size":"1 x 8 mL", "name":"Stop Solution", "number":"AB100617-CMP08", "productcode":"" }, { "size":"2 x 1 Vial", "name":"Recombinant Human Osteoprotegerin Standard (lyophilized)", "number":"AB100617-CMP02", "productcode":"" }, { "size":"1 x 200 µL", "name":"500X HRP-Streptavidin Concentrate", "number":"AB100617-CMP05", "productcode":"" }, { "size":"1 x 15 mL", "name":"5X Assay Diluent B", "number":"AB100617-CMP07", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Osteoprotegerin Microplate (12 x 8 wells)", "number":"AB100617-CMP01", "productcode":"" }, { "size":"1 x 12 mL", "name":"TMB One-Step Substrate Reagent", "number":"AB100617-CMP09", "productcode":"" }, { "size":"1 x 30 mL", "name":"Assay Diluent A", "number":"AB100617-CMP06", "productcode":"" }, { "size":"2 x 1 Vial", "name":"Biotinylated anti-Human Osteoprotegerin", "number":"AB100617-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Osteoprotegerin (OPG) also known as osteoclastogenesis inhibitory factor is a glycoprotein with a mass of approximately 60 kDa. It acts as a soluble decoy receptor for receptor activator of nuclear factor kappa-β ligand (RANKL) and is encoded by the TNFRSF11B gene. OPG is mainly expressed in osteoblasts fibroblasts and endothelial cells. Its expression can be found in diverse tissues throughout the body including the liver and lungs.
Biological function summary

OPG inhibits the differentiation and activation of osteoclasts by binding to RANKL preventing its interaction with the receptor RANK on the surface of osteoclast progenitor cells. As part of a non-classical signaling pathway OPG plays a significant role in the regulation of bone remodeling and maintenance by controlling bone resorption. This activity preserves bone density and structure by limiting excessive osteoclastic activity.

Pathways

OPG operates within the RANK/RANKL/OPG signaling axis which is important for bone metabolism. It counteracts the bone-resorption pathway driven by the RANKL-RANK interaction inhibiting osteoclastogenesis. This axis involves interactions with other proteins such as RANK RANKL and TRAIL where TRAIL's involvement hints towards a broader immune regulation role for OPG.

OPG has a significant association with conditions such as osteoporosis and vascular calcification. In osteoporosis an imbalance in the RANKL/OPG ratio can lead to excessive bone loss due to increased osteoclast activity. In vascular calcification OPG appears to play a protective role likely linked with regulatory mechanisms involving RANKL and TRAIL. Understanding these interactions opens potential therapeutic avenues particularly in managing bone-related and cardiovascular conditions.

Product protocols

Target data

Acts as a decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.
See full target information TNFRSF11B

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Molecular therapy : the journal of the American Society of Gene Therapy 32:3932-3954 PubMed39244641

2024

Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing.

Applications

Unspecified application

Species

Unspecified reactive species

Cristiano Fieni,Stefania Livia Ciummo,Carlo Sorrentino,Simona Marchetti,Simone Vespa,Paola Lanuti,Lavinia Vittoria Lotti,Emma Di Carlo

Frontiers in endocrinology 15:1359052 PubMed39157681

2024

Investigating mechanical and inflammatory pathological mechanisms in osteoarthritis using MSC-derived osteocyte-like cells in 3D.

Applications

Unspecified application

Species

Unspecified reactive species

Sophie J Gilbert,Ryan Jones,Ben J Egan,Cleo Selina Bonnet,Sam L Evans,Deborah J Mason

JCI insight 9: PubMed38780544

2024

Methionine as a regulator of bone remodeling with fasting.

Applications

Unspecified application

Species

Unspecified reactive species

Tânia Amorim,Naveen Gv Kumar,Natalie L David,William Dion,Trishya Pagadala,Nandini K Doshi,Bokai Zhu,Andrey Parkhitko,Matthew L Steinhauser,Pouneh K Fazeli

BMC oral health 24:52 PubMed38191383

2024

Postmenopausal women with HIV have increased tooth loss.

Applications

Unspecified application

Species

Unspecified reactive species

Sunil Wadhwa,Taylor R Finn,Karolina Kister,Satoko Matsumura,Michael Levit,Anyelina Cantos,Jayesh Shah,Bruno Bohn,Evanthia Lalla,John T Grbic,Ryan T Demmer,Michael T Yin

British journal of pharmacology 181:429-446 PubMed37625900

2023

Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL-induced osteoclastogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ayda Henriques Schneider,Thaise Mayumi Taira,Gabriel Azevedo Públio,Douglas da Silva Prado,Paula Barbim Donate Yabuta,Jéssica Cristina Dos Santos,Caio Cavalcante Machado,Flávio Falcão Lima de Souza,Lucas Gabriel Rodrigues Venturini,Renê Donizeti Ribeiro de Oliveira,Thiago Mattar Cunha,José Carlos Alves-Filho,Paulo Louzada-Júnior,Tarcília Aparecida da Silva,Sandra Yasuyo Fukada,Fernando Queiróz Cunha

Materials (Basel, Switzerland) 15: PubMed35955174

2022

Evaluation of the Biocompatibility and Osteogenic Properties of Metal Oxide Coatings Applied by Magnetron Sputtering as Potential Biofunctional Surface Modifications for Orthopedic Implants.

Applications

Unspecified application

Species

Unspecified reactive species

Mariana Fernández-Lizárraga,Julieta García-López,Sandra E Rodil,Rosa María Ribas-Aparicio,Phaedra Silva-Bermudez

The Korean journal of internal medicine 37:821-829 PubMed35468703

2022

Benefits of lumican on human bone health: clinical evidence using bone marrow aspirates.

Applications

Unspecified application

Species

Unspecified reactive species

Yun Sun Lee,So Jeong Park,Jin Young Lee,Eunah Choi,Beom-Jun Kim

Polymers 13: PubMed34641117

2021

Synergies of Human Umbilical Vein Endothelial Cell-Laden Calcium Silicate-Activated Gelatin Methacrylate for Accelerating 3D Human Dental Pulp Stem Cell Differentiation for Endodontic Regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Wei-Yun Lai,Tzu-Hsin Lee,Jian-Xun Chen,Hooi-Yee Ng,Tsui-Hsien Huang,Ming-You Shie

Acta biomaterialia 135:689-704 PubMed34520883

2021

Biomimetic versus sintered macroporous calcium phosphate scaffolds enhanced bone regeneration and human mesenchymal stromal cell engraftment in calvarial defects.

Applications

Unspecified application

Species

Unspecified reactive species

Meadhbh Á Brennan,David S Monahan,Bénédicte Brulin,Sara Gallinetti,Paul Humbert,Christina Tringides,Cristina Canal,Maria Pau Ginebra,Pierre Layrolle

Diagnostics (Basel, Switzerland) 11: PubMed34206615

2021

A Novel Combination of Blood Biomarkers and Clinical Stroke Scales Facilitates Detection of Large Vessel Occlusion Ischemic Strokes.

Applications

Unspecified application

Species

Unspecified reactive species

Edoardo Gaude,Barbara Nogueira,Marcos Ladreda Mochales,Sheila Graham,Sarah Smith,Lisa Shaw,Sara Graziadio,Gonzalo Ladreda Mochales,Philip Sloan,Joshua D Bernstock,Shashank Shekhar,Toby I Gropen,Christopher I Price
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com